Package Leaflet: Information for the User
Pantoprazole Bluefish 20 mg Gastro-Resistant Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Pantoprazole Bluefish contains the active substance pantoprazole. Pantoprazole is a selective inhibitor of the "proton pump", a medicine that reduces the amount of acid produced in your stomach. It is used for the treatment of diseases related to stomach and intestine acid.
Pantoprazole is used in adults and adolescents from 12 years of age to treat:
Pantoprazole is used in adults to treat:
Prevention of gastroduodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs, such as ibuprofen) in patients at risk who require continued treatment with NSAIDs.
Consult your doctor or pharmacist or nurse before starting to take Pantoprazole Bluefish:
Tell your doctor immediately, before or after taking this medicine, if you notice any of the following symptoms, which may be signs of more serious diseases:
Your doctor will decide if you need any additional tests to rule out a malignant disease because pantoprazole can alleviate the symptoms of cancer and may delay its diagnosis. If, despite treatment, your symptoms persist, complementary tests will be performed.
If you take Pantoprazole Bluefish for a prolonged period (more than a year), your doctor may monitor you regularly. You should inform your doctor of any new symptoms and/or unexpected events each time you visit your doctor.
Pantoprazole Bluefish is not recommended for use in children as it has not been tested in children under 12 years of age.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Pantoprazole Bluefish may affect the effectiveness of other medicines, inform your doctor if you are taking:
There is not enough data on the use of pantoprazole in pregnant women. It has been reported that in humans, pantoprazole is excreted in breast milk.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
You should only use this medicine if your doctor considers that the benefit to you is greater than the potential risk to the fetus or baby.
Pantoprazole Bluefish has no or negligible influence on the ability to drive or use machines.
Do not drive or use machines if you experience side effects such as dizziness and visual disturbances.
Pantoprazole Bluefish contains Sodium
This medicine contains less than 1 mmol of sodium (23 mg) per gastro-resistant tablet; this is essentially "sodium-free".
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Method of Administration
Take the tablets 1 hour before meals without chewing or breaking them. Swallow them whole with water.
The recommended dose is:
Adults and adolescents from 12 years of age:
For treating symptoms associated with gastroesophageal reflux disease (heartburn, acid reflux, pain when swallowing)
The usual dose is one tablet per day. This dose usually provides relief within 2-4 weeks, and if not, at most, within the following 4 weeks. Your doctor will tell you how long you should continue taking the medicine. After that, any recurring symptoms can be controlled by taking one tablet per day, as needed.
For long-term treatment and prevention of relapses of reflux esophagitis
The usual dose is one tablet per day. If the disease returns, your doctor may double the dose, in which case you can take Pantoprazole Bluefish 40 mg once a day. After healing, you can reduce the dose back to one 20 mg tablet per day.
Adults:
For the prevention of duodenal and stomach ulcers in patients who require continued treatment with NSAIDs
The usual dose is one tablet per day.
Patients with liver problems:
If you have severe liver problems, you should not take more than one 20 mg tablet per day.
Use in children and adolescents:
Pantoprazole Bluefish is not recommended for use in children under 12 years of age.
Inform your doctor or pharmacist or call the Toxicology Information Service telephone 91 562 04 20, indicating the medicine and the amount taken.
No symptoms of overdose are known.
Do not take a double dose to make up for forgotten doses. Take your next dose as usual.
Do not stop taking these tablets without consulting your doctor or pharmacist first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following side effects, stop taking these tablets and inform your doctor immediately or contact the emergency department of the nearest hospital.
Other side effects are:
Common(may affect up to 1 in 10 people):
Benign polyps in the stomach.
Uncommon(may affect up to 1 in 100 people):
Headache; dizziness; diarrhea; feeling of dizziness, vomiting; bloating and flatulence (gas); constipation; dry mouth; abdominal pain and discomfort; skin rash, exanthema, eruption; itching; feeling of weakness, fatigue, or general malaise; sleep disturbances; hip, wrist, and spine fractures.
Rare(may affect up to 1 in 1,000 people):
Alteration or complete loss of taste, vision disturbances such as blurred vision; hives; joint pain; muscle pain; weight changes; increased body temperature; high fever; swelling in the limbs (peripheral edema); allergic reactions; depression; breast enlargement in men, agranulocytosis (severe decrease in the number of white blood cells in the blood, making infections more likely), taste disturbances.
Very rare(may affect up to 1 in 10,000 people):
Disorientation.
Not known(frequency cannot be estimated from the available data):
Hallucinations, confusion (especially in patients with a history of these symptoms), tingling, pinching, numbness, burning sensation, skin rash, possibly with joint pain.
Persistent watery diarrhea.
Side effects identified through blood tests:
Uncommon(may affect up to 1 in 100 people): increased liver enzymes.
Rare(may affect up to 1 in 1,000 people): increased bilirubin; increased blood fat levels, sharp drop in white blood cells, associated with high fever.
Very rare(may affect up to 1 in 10,000 people): reduction in platelet count, which could lead to bleeding or more bruising than usual; reduction in white blood cell count, which could lead to more frequent infections; abnormal reduction in the balance between red and white blood cells, as well as platelets.
Frequency not known(cannot be estimated from the available data)
decrease in sodium, magnesium, calcium, or potassium levels in the blood (see section 2).
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of sight and reach of children.
Store below 30 °C.
Do not use this medicine after the expiry date which is stated on the packaging after "EXP:". The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Pantoprazole Bluefish 20 mg gastro-resistant tablets are yellow, oval, biconvex, smooth. The dimensions of the tablets are as follows:
Pack sizes:
Blister packs with: 14, 28, 56, and 100 gastro-resistant tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder
Bluefish Pharmaceuticals AB
P.O. Box 49013;
100 28 Stockholm;
Sweden
Manufacturer
Bluefish Pharmaceuticals AB
Gävlegatan 22,
113 30 Stockholm,
Sweden
Teva Pharma, S.L.U.,
C/ C, nº 4, Polígono Industrial Malpica
50016 Zaragoza,
Spain
Further information about this medicinal product can be obtained from the local representative of the marketing authorization holder:
Bluefish Pharma S.L.U.,
AP 36007, 2832094 Madrid,
Branch 36
Member State | Medicinal Product Name |
Austria | Pantoprazole Bluefish 20 mg stomach acid-resistant tablets |
Denmark | Pantoprazole Bluefish 20 mg |
Ireland (RMS) | Pantoprazole Bluefish 20 mg gastro-resistant tablet |
Italy | Tecnozol 20 mg gastro-resistant tablets |
Poland | Pantoprazole Bluefish, 20 mg, enteric-coated tablets |
Portugal | Pantoprazol Bluefish 20 mg Gastro-resistant Tablets |
Spain | Pantoprazol Bluefish 20 mg gastro-resistant tablets EFG |
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/